journal article·2024-09-11Open access

Machine Learning for Prediction of Cognitive Deterioration in Patients with Early Parkinson’s Disease

Maitane Martinez-Eguiluz, Olatz Arbelaitz, Ibai Gurrutxaga, Javier Muguerza, Juan Carlos Gomez-Esteban, Iñigo Gabilondo, Ane Murueta-Goyena

Applied Sciences· Volume 14· Issue 18

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder marked by motor and cognitive impairments. The early prediction of cognitive deterioration in PD is crucial. This work aims to predict the change in the Montreal Cognitive Assessment (MoCA) at years 4 and 5 from baseline in the Parkinson’s Progression Markers Initiative database. The predictors included demographic and clinical variables: motor and non-motor symptoms from the baseline visit and change scores from baseline to the first-year follow-up. Various regression models were compared, and SHAP (SHapley Additive exPlanations) values were used to assess domain importance, while model coefficients evaluated variable importance. The LASSOLARS algorithm outperforms other models, achieving lowest the MAE, 1.55±0.23 and 1.56±0.19, for the fourth- and fifth-year predictions, respectively. Moreover, when trained to predict the average MoCA score change across both time points, its performance improved, reducing its MAE by 19%. Baseline MoCA scores and MoCA deterioration over the first-year were the most influential predictors of PD (highest model coefficients). However, the cumulative effect of other cognitive variables also contributed significantly. This study demonstrates that mid-term cognitive deterioration in PD can be accurately predicted from patients’ baseline cognitive performance and short-term cognitive deterioration, along with a few easily measurable clinical measurements.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Parkinson's Disease Mechanisms and Treatments · Neurological disorders and treatments · Dementia and Cognitive Impairment Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Computer Architecture and Technology, University of the Basque Country, UPV/EHU, 20018 Donostia, Spain

Department of Neurosciences, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain

Neurodegenerative Diseases Group, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain

Department of Neurology, Cruces University Hospital, 48903 Barakaldo, Spain

Ikerbasque Basque Foundation of Science, 48009 Bilbao, Spain

Funding

Basque Government · MICIU/AEI/10.13039/501100011033 · FEDER · UE · Department of Economic Development and Competitiveness of the Basque Government

References (21)

Show source-provided references
1. Arshad, H., Tayyab, M., Bilal, M., Akhtar, S., and Abdullahi, A. (2024). Trends and Challenges in harnessing big data intelligence for health care transformation. Artif. Intell. Intell. Syst., 220–240.10.1201/9781003496410-14 ↗
2. Risk of dementia in Parkinson’s disease: A community-based, prospective study10.1212/WNL.56.6.730 ↗
3. The epidemiology of dementia associated with Parkinson’s disease10.1111/j.1750-3639.2009.00369.x ↗
4. Parkinson disease-associated cognitive impairment10.1038/s41572-021-00280-3 ↗
5. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease10.1212/WNL.0b013e3181c34b47 ↗
6. Gramotnev, G., Gramotnev, D.K., and Gramotnev, A. (2019). Parkinson’s disease prognostic scores for progression of cognitive decline. Sci. Rep., 9.10.1038/s41598-019-54029-w ↗
7. Nguyen, A.A., Maia, P.D., Gao, X., Damasceno, P.F., and Raj, A. (2020). Dynamical role of pivotal brain regions in Parkinson symptomatology uncovered with deep learning. Brain Sci., 10.10.3390/brainsci10020073 ↗
8. The Parkinson progression marker initiative (PPMI)10.1016/j.pneurobio.2011.09.005 ↗
9. Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease10.1038/s41531-022-00409-5 ↗
10. Gorji, A., and Fathi Jouzdani, A. (2024). Machine learning for predicting cognitive decline within five years in Parkinson’s disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers. PLoS ONE, 19.10.1371/journal.pone.0304355 ↗
11. Salmanpour, M.R., Shamsaei, M., Saberi, A., Setayeshi, S., Klyuzhin, I.S., Sossi, V., and Rahmim, A. (2019). Optimized machine learning methods for prediction of cognitive outcome in Parkinson’s disease. Comput. Biol. Med., 111.10.1016/j.compbiomed.2019.103347 ↗
12. Hosseinzadeh, M., Gorji, A., Fathi Jouzdani, A., Rezaeijo, S.M., Rahmim, A., and Salmanpour, M.R. (2023). Prediction of Cognitive decline in Parkinson’s Disease using clinical and DAT SPECT Imaging features, and Hybrid Machine Learning systems. Diagnostics, 13.10.3390/diagnostics13101691 ↗
13. Almgren, H., Camacho, M., Hanganu, A., Kibreab, M., Camicioli, R., Ismail, Z., Forkert, N.D., and Monchi, O. (2023). Machine learning-based prediction of longitudinal cognitive decline in early Parkinson’s disease using multimodal features. Sci. Rep., 13.10.1038/s41598-023-37644-6 ↗
14. Long-term cognitive decline prediction based on multi-modal data using Multimodal3DSiameseNet: Transfer learning from Alzheimer’s disease to Parkinson’s disease10.1007/s11548-023-02866-6 ↗
15. The MoCA: Well-suited screen for cognitive impairment in Parkinson disease10.1212/WNL.0b013e3181fc29c9 ↗
16. Montreal Cognitive Assessment Test: Normalization and standardization for Spanish population
17. A fast and elitist multiobjective genetic algorithm: NSGA-II10.1109/4235.996017 ↗
18. Modeling of internal combustion engine emissions by LOLIMOT algorithm10.1016/j.protcy.2012.03.027 ↗
19. Bergstra, J., Yamins, D., and Cox, D. (2013, January 17–19). Making a science of model search: Hyperparameter optimization in hundreds of dimensions for vision architectures. Proceedings of the International Conference on Machine Learning, PMLR, Atlanta, GA, USA. Available online: https://proceedings.mlr.press/v28/bergstra13.html.
20. Algorithms for hyper-parameter optimization
21. Lundberg, S.M., and Lee, S.I. (2017). A unified approach to interpreting model. Adv. Neural Inf. Process. Syst., 30.